Overview

Dry Eye Assessment and Management Study

Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
The objective of the DREAM study is to evaluate the effectiveness and safety of supplementation with omega-3 fatty acids in relieving the symptoms of moderate to severe dry eye disease.
Phase:
Phase 3
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Eye Institute (NEI)